Back to Search
Start Over
A pilot clinical study of an add-on Ayurvedic formulation containing Tinospora cordifolia and Piper longum in mild to moderate COVID-19
- Source :
- Journal of Ayurveda and Integrative Medicine, Vol 13, Iss 2, Pp 100454-(2022)
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
-
Abstract
- Background: After declaration of COVID- 19 as pandemic by WHO, countries adopted several measures to contain the spread as well as test and treat the patients. Further, as no effective management protocols to address this pandemic were available, a need was felt to explore the integration of modern and traditional medicines to treat COVID- 19 cases. Objective: To undertake a study with Ayurveda formulation as add on to existing standard of care (SOC) and to compare the outcomes in terms of patient acceptability, the time to clinical recovery, hospital stay as well as any signs of drug-herb interaction between the Ayurveda formulation and the SOC. Material and methods: An exploratory nonrandomized prospective study has been undertaken for comparing the outcomes of traditional Ayurvedic classical formulation of Tinospora cordifolia (Guduchi) and Piper longum (Pippali) as an add on to standard of care (SOC) using modern medicine with SOC alone. This has been done in mild and moderate COVID- 19 cases, at a tertiary care integrative Medicine hospital in the National Capital Region, Gurgaon, India. The outcomes have been evaluated in terms of the duration of hospital stay, the time to clinical recovery, safety and non- interference/interaction of Ayurvedic and Further, long term impact of COVID- 19 treatment has been evaluated using quality of life questionnaire after 3 months of discharge. Results: Findings of present study reveals that the Ayurveda add-on formulation of T. cordifolia (Guduchi) and P. longum (Pippali) has reduced the length of hospital stay and improve the recovery time. General feeling of wellbeing and activity levels were better in the 3 month follow-up post discharge in the Ayurveda add-on group. Conclusion: Addition of Ayurveda formulation has reduced the time of recovery and duration of hospital stay. However, this formulation needs further investigated to provide more information on effective and safe herbal add-on to SOC for better outcomes to treatment of COVID-19 disease.
- Subjects :
- Modern medicine
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
0211 other engineering and technologies
National capital region
02 engineering and technology
Tinospora cordifolia
Clinical study
03 medical and health sciences
0302 clinical medicine
Quality of life (healthcare)
021105 building & construction
Drug Discovery
Medicine
Miscellaneous systems and treatments
Prospective cohort study
biology
business.industry
RZ409.7-999
COVID-19
biology.organism_classification
030205 complementary & alternative medicine
Complementary and alternative medicine
Piper longum
Family medicine
Integrative medicine
business
Ayurveda
Subjects
Details
- ISSN :
- 09759476
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Journal of Ayurveda and Integrative Medicine
- Accession number :
- edsair.doi.dedup.....fe140283962247a41dfb2ce200a26916
- Full Text :
- https://doi.org/10.1016/j.jaim.2021.05.008